Charles River Laboratories Intl. Inc (N:CRL)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for CRL within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 28th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 28/20 Feb 27/20 Chubb Stephen D Direct Ownership Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -3,140  
Feb 28/20 Feb 27/20 Chubb Stephen D Direct Ownership Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -4,030  
Feb 28/20 Feb 27/20 Chubb Stephen D Direct Ownership Common Stock S - Open market or private sale -2,464 $160.89
Feb 28/20 Feb 27/20 Chubb Stephen D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,140 $70.29
Feb 28/20 Feb 27/20 Chubb Stephen D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,030 $43.39
Feb 27/20 Feb 26/20 Smith David Ross Direct Ownership Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -4,188  
Feb 27/20 Feb 26/20 Smith David Ross Direct Ownership Common Stock S - Open market or private sale -738 $164.19
Feb 27/20 Feb 26/20 Smith David Ross Direct Ownership Common Stock S - Open market or private sale -657 $163.38
Feb 27/20 Feb 26/20 Smith David Ross Direct Ownership Common Stock S - Open market or private sale -1,027 $162.27
Feb 27/20 Feb 26/20 Smith David Ross Direct Ownership Common Stock S - Open market or private sale -898 $161.58
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CRL within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 28th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 28/20 Feb 27/20 Chubb Stephen D Direct Ownership Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -3,140  
Feb 28/20 Feb 27/20 Chubb Stephen D Direct Ownership Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -4,030  
Feb 28/20 Feb 27/20 Chubb Stephen D Direct Ownership Common Stock S - Open market or private sale -2,464 $160.89
Feb 28/20 Feb 27/20 Chubb Stephen D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,140 $70.29
Feb 28/20 Feb 27/20 Chubb Stephen D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,030 $43.39
Feb 27/20 Feb 26/20 Smith David Ross Direct Ownership Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -4,188  
Feb 27/20 Feb 26/20 Smith David Ross Direct Ownership Common Stock S - Open market or private sale -738 $164.19
Feb 27/20 Feb 26/20 Smith David Ross Direct Ownership Common Stock S - Open market or private sale -657 $163.38
Feb 27/20 Feb 26/20 Smith David Ross Direct Ownership Common Stock S - Open market or private sale -1,027 $162.27
Feb 27/20 Feb 26/20 Smith David Ross Direct Ownership Common Stock S - Open market or private sale -898 $161.58
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CRL